Symbol
| CTCFL
| contributors: mct/pgu - updated : 13-04-2020
|
HGNC name
| CCCTC-binding factor (zinc finger protein)-like
|
HGNC id
| 16234
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in juvenile angiofibroma in the posterior nasal cavity of adolescent males | tumoral
|  
|  
| --other
|  
|
aberrantly expressed in melanoma | tumoral
|  
|  
| --over
|  
|
in high-grade epithelial ovarian cancer | |
Variant & Polymorphism
|
| |
Candidate gene
| candidate protein for the elusive epigenetic reprogramming factor acting in the male germ line |
|
potential practical applications as a molecular biomarker of breast cancer |
Marker
| aberrant CTCFL hypomethylation is a promising biomarker for the prognosis of hepatocellular carcinoma |
Therapy target
| has the potential to be used as a prognostic biomarker and to yield novel drug targets among the genes CTCFL controls in serous ovarian cancer (SOC) patients |
|
| Mice homozygous for the null allele had a defect in spermatogenesis that resulted in small testes associated with increased cell death |